» Articles » PMID: 32938749

Developments in Mass Spectrometry for Glycosaminoglycan Analysis: A Review

Overview
Date 2020 Sep 17
PMID 32938749
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

This review covers recent developments in glycosaminoglycan (GAG) analysis via mass spectrometry (MS). GAGs participate in a variety of biological functions, including cellular communication, wound healing, and anticoagulation, and are important targets for structural characterization. GAGs exhibit a diverse range of structural features due to the variety of O- and N-sulfation modifications and uronic acid C-5 epimerization that can occur, making their analysis a challenging target. Mass spectrometry approaches to the structure assignment of GAGs have been widely investigated, and new methodologies remain the subject of development. Advances in sample preparation, tandem MS techniques (MS/MS), online separations, and automated analysis software have advanced the field of GAG analysis. These recent developments have led to remarkable improvements in the precision and time efficiency for the structural characterization of GAGs.

Citing Articles

Improved Detection of Polysulfated Oligosaccharides by Mass Spectrometry Applicable to Miniaturized Samples.

Jeanroy F, Gil J, Comby-Zerbino C, Demesmay C, Dugas V Molecules. 2024; 29(23).

PMID: 39683801 PMC: 11643541. DOI: 10.3390/molecules29235642.


Mass Spectrometry Imaging with Trapped Ion Mobility Spectrometry Enables Spatially Resolved Chondroitin, Dermatan, and Hyaluronan Glycosaminoglycan Oligosaccharide Analysis .

Devlin A, Green F, Takats Z Anal Chem. 2024; 96(45):17969-17977.

PMID: 39476845 PMC: 11561879. DOI: 10.1021/acs.analchem.4c02706.


Molecular analysis of the extracellular microenvironment: from form to function.

Macdonald J, Mehta A, Drake R, Angel P FEBS Lett. 2024; 598(6):602-620.

PMID: 38509768 PMC: 11049795. DOI: 10.1002/1873-3468.14852.


Vaccines and Therapeutics for COVID-19 - How Can Understanding SARS-CoV-2 Glycosylation Lead to Pharmaceutical Advances?.

Gleinich A, Pepi L, Shajahan A, Heiss C, Azadi P Am Pharm Rev. 2023; 24(4):14-21.

PMID: 38099300 PMC: 10721230.


Extension of the SUGRES-1P Coarse-Grained Model of Polysaccharides to Heparin.

Danielsson A, Samsonov S, Liwo A, Sieradzan A J Chem Theory Comput. 2023; 19(17):6023-6036.

PMID: 37587433 PMC: 10500997. DOI: 10.1021/acs.jctc.3c00511.


References
1.
Ouyang Y, Zeng Y, Rong Y, Song Y, Shi L, Chen B . Profiling analysis of low molecular weight heparins by multiple heart-cutting two dimensional chromatography with quadruple time-of-flight mass spectrometry. Anal Chem. 2015; 87(17):8957-63. DOI: 10.1021/acs.analchem.5b02218. View

2.
Khanal N, Masellis C, Kamrath M, Clemmer D, Rizzo T . Glycosaminoglycan Analysis by Cryogenic Messenger-Tagging IR Spectroscopy Combined with IMS-MS. Anal Chem. 2017; 89(14):7601-7606. PMC: 5675075. DOI: 10.1021/acs.analchem.7b01467. View

3.
Wu J, Wei J, Hogan J, Chopra P, Joshi A, Lu W . Negative Electron Transfer Dissociation Sequencing of 3-O-Sulfation-Containing Heparan Sulfate Oligosaccharides. J Am Soc Mass Spectrom. 2018; 29(6):1262-1272. PMC: 6004244. DOI: 10.1007/s13361-018-1907-0. View

4.
Bohlmann L, Tredwell G, Yu X, Chang C, Haselhorst T, Winger M . Functional and structural characterization of a heparanase. Nat Chem Biol. 2015; 11(12):955-7. DOI: 10.1038/nchembio.1956. View

5.
Shao C, Shi X, Phillips J, Zaia J . Mass spectral profiling of glycosaminoglycans from histological tissue surfaces. Anal Chem. 2013; 85(22):10984-91. PMC: 3872031. DOI: 10.1021/ac402517s. View